AMNEAL PHARMACEUTICALS INC (AMRX) Stock Analyst Ratings
NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to AMRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.73. This target is 60.25% above the current price.
AMRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AMRX.
In the previous month the buy percentage consensus was at a similar level.
AMRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-03 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-24 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-11-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-02 | Truist Securities | Maintains | Buy -> Buy |
| 2024-09-06 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2024-08-13 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-12 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-06 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-05-06 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-03-21 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-04 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-29 | Barclays | Maintains | Overweight -> Overweight |
| 2023-11-08 | Truist Securities | Maintains | Buy -> Buy |
| 2023-09-06 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-07 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-07 | Truist Securities | Maintains | Buy -> Buy |
| 2023-08-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-05-08 | Piper Sandler | Maintains | Overweight |
| 2023-03-29 | Truist Securities | Maintains | Buy |
| 2023-03-10 | Barclays | Maintains | Overweight |
| 2023-03-03 | BMO Capital | Maintains | Market Perform |
| 2023-03-03 | Goldman Sachs | Maintains | Buy |
| 2022-08-08 | Goldman Sachs | Maintains | Buy |
| 2022-05-12 | Goldman Sachs | Maintains | Buy |
| 2021-03-08 | Goldman Sachs | Upgrade | Sell -> Buy |